Researchers discover new 'trick' steroids use to suppress inflammation

January 14, 2015, Georgia State University

A new "trick" steroids use to suppress inflammation, which could be used to make new anti-inflammatory drugs without the harmful side effects of steroids, has been discovered by researchers at Georgia State University.

Their findings have been published in the journal Nature Communications.

Glucocorticoids, a class of steroid hormones, are among the most commonly used anti-inflammatory agents. Steroids have been effective at suppressing , but if used for long-term treatment they can cause serious such as increased risk of infections, liver damage, fluid retention, increased blood pressure, weight gain, easy bruising and slower wound healing.

There is an urgent need to develop novel anti-inflammatory strategies to combat inflammation, which is the cause of many human diseases. Inflammation has been linked to cancer, pulmonary diseases, infectious diseases, neurological diseases, arthritis, otitis media (ear infections) and obesity. It is the human body's response to harmful stimuli, such as pathogens or damaged tissues, but an overactive response, too much inflammation, is detrimental and leads to disease. As a result, inflammation must be tightly regulated.

"Chronic inflammatory diseases last for months and years, so you have to have a medicine that can be used for treating inflammation for the long term without having side effects," said Dr. Jian-Dong Li, a lead investigator of the study and director of the Institute for Biomedical Sciences at Georgia State and also a Georgia Research Alliance Eminent Scholar.

It hasn't been fully understood how glucocorticoids control overactive inflammatory response, but this study found a previously unknown, underlying mechanism that steroids use to suppress inflammation. Scientists already knew that steroids suppress inflammation by directly targeting nuclear factor-κB (NF-κB), a master regulator of pro-inflammatory mediators.

"We have found also suppress inflammation by upregulating IRAK-M, a key negative regulator of inflammatory pathways," Li said.

The researchers found glucocorticoids tightly control bacteria-induced innate immune and inflammatory response by enhancing IRAK-M, one of the most critical negative feedback regulators of inflammation that inhibits the activation of the proteins MyD88 and IRAK1/4.

They propose that IRAK-M is a novel target of glucocorticoids to suppress bacteria-induced inflammation. The study provides new insights into the previously unidentified role of glucocorticoids in suppressing inflammation by targeting the central bottleneck proteins MyD88 and IRAK1/4.

This discovery could lead to the development of new therapeutic strategies to control overactive inflammation, Li said.

"We congratulate Dr. Li and his research team on their discovery and for having their findings published in Nature Communications," said C. Michael Cassidy, president and chief executive officer of Georgia Research Alliance. "Scientific breakthroughs stemming from Georgia's research universities are critical components to bringing life-changing therapies to market."

Explore further: Key pathway to stop dangerous, out-of-control inflammation discovered

Related Stories

Key pathway to stop dangerous, out-of-control inflammation discovered

April 9, 2013
A potential new strategy to developing new drugs to control inflammation without serious side effects has been found by Georgia State University researchers and international colleagues.

New anti-inflammatory drugs might help avoid side effects of steroids

October 25, 2011
A new class of anti-inflammatory drugs may one day serve as an alternative to steroid medications and possibly help avoid the serious side effects of steroids, based on research findings at the Salk Institute for Biological ...

Alterations in fatty acid synthesis linked to sepsis inflammation

January 9, 2015
Sepsis is a leading cause of death for patients in intensive care units. The excessive systemic inflammation in individuals with sepsis damages organs and can lead to death. Therapeutic options for sepsis are limited and ...

Team finds mechanism of toxin's inflammatory effect on lungs

December 29, 2014
A study released Dec. 23 describes a never-before-seen mechanism by which a bacterial toxin leads to severe inflammation in asthma and other acute and chronic pulmonary diseases. Researchers from The University of Texas Health ...

Protein appears to protect against bone loss in arthritis

September 12, 2014
A small protein named GILZ appears to protect against the bone loss that often accompanies arthritis and its treatment, researchers report.

Feijoa and blackberry help reduce inflammation

January 6, 2015
Feijoa and blackberry are two fruits with a strong anti-inflammatory effect that could help people with inflammatory diseases, according to recent research from the University of Auckland.

Recommended for you

LincRNAs identified in human fat tissue

June 21, 2018
A large team of researchers from the U.S. and China has succeeded in identifying a number of RNA fragments found in human fat tissue. In their paper published in the journal Science Translational Medicine the group describes ...

Key molecule of aging discovered

June 21, 2018
Every cell and every organism ages sooner or later. But why is this so? Scientists at the German Cancer Research Center in Heidelberg have now discovered for the first time a protein that represents a central switching point ...

Compound made inside human body stops viruses from replicating

June 20, 2018
The newest antiviral drugs could take advantage of a compound made not by humans, but inside them. A team of researchers has identified the mode of action of viperin, a naturally occurring enzyme in humans and other mammals ...

Research reveals zero proof probiotics can ease your anxiety

June 20, 2018
If you're expecting probiotics to reduce your anxiety, it might be time to put down that yogurt spoon—or supplement bottle—and call a professional instead.

Simple sugar delays neurodegeneration caused by enzyme deficiency

June 20, 2018
A new therapeutic approach may one day delay neurodegeneration typical of a disease called mucopolysaccharidoses IIIB (MPS IIIB). Neurodegeneration in this condition results from the abnormal accumulation of essential cellular ...

Long-term estrogen therapy changes microbial activity in the gut, study finds

June 20, 2018
Long-term therapy with estrogen and bazedoxifene alters the microbial composition and activity in the gut, affecting how estrogen is metabolized, a new study in mice found.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

EyeNStein
not rated yet Jan 14, 2015
Excellent. So if they can get a steroid to bind to an inflammation marker cell (like Azithromycin binds to phagocytes) without impeding this newly discovered binding: The effectiveness/side effects ratio could be greatly improved.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.